Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Medoxomil in Hypertensive Patients with T2DM
NCT02517866Phase 4Completed
- Sponsor
- Takeda
- Start
- Jul 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Jul 2015; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02517866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517866.